|
Oddělení: Neurochemie Seznam publikací v časopisech s impaktem. Autoři z oddělení jsou označeni červeně. Autoři FGU podtržením jména. Aktualizováno 19.03.2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 2011 1. Jakubík J. - Janíčková H. - El-Fakahany E. E. - Doležal V. Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy. British Journal of Pharmacology, 162(5), 1029-1044, 2011 IF = 4,925(10) 2. Lyukmanova E. N. - Shenkarev Z. O. - Shulepko M. A. - Mineev K. S. - D´Hoedt D. - Kasheverov I. E. - Filkin S. Yu. - Krivolapova A. P. - Janíčková H. - Doležal V. - Dolgikh D. A. - Arseniev A. S. - Bertrand D. - Tsetlin V.I. - Kirpichnikov M. P. NMR Structure and Action on Nicotinic Acetylcholine Receptors of Water-soluble Domain of Human LYNX1. Journal of Biological Chemistry, 286(12), 10618-10627, 2011 IF = 5,328(10) 3. Jakubík J. - Janíčková H. - Randáková A. - El-Fakahany E. E. - Doležal V. Subtype Differences in Pre-Coupling of Muscarinic Acetylcholine Receptors. PLoS ONE, 6(11), e27732, 2011 IF = 4,411(10) 2010 1. Machová E. - Rudajev V. - Smyčková H. - Koivisto H. - Tanila H. - Doležal V. Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice. Neurobiology of Disease, 38(1), 27-35, 2010 IF = 5,121(10) 2. Grant M.K.O. - Noetzel M.J. - De Lorme K.C. - Jakubík J. - Doležal V. - El-Fakahany E. E. Pharmacological Evaluation of the Long-Term Effects of Xanomeline on the M1 Muscarinic Acetylcholine Receptor. PLoS ONE, 5(12), e15722-16, 2010 IF = 4,411(10) 2009 1. Michal P. - Rudajev V. - El-Fakahany E. E. - Doležal V. Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways. European Journal of Pharmacology, 606, 50-60, 2009 IF = 2,585(09) 2. Mordvintsev D.Y. - Polyak Y.L. - Rodionov D.I. - Jakubík J. - Doležal V. - Karlsson E. - Tsetlin V.I. - Utkin Y.N. Weak toxin WTX from Naja kaouthia cobra venom interacts with both nicotinic and muscarinic acetylcholine receptors. FEBS Journal, 276(18), 5065-5075, 2009 IF = 3,042(09) 3. Machová E. - O´Regan S. - Newcombe J. - Meunier F. M. - Prentice J. - Dove R. - Lisá V. - Doležal V. Detection of choline transporter-like 1 protein CTL1 in neuroblastoma × glioma cells and in the CNS, and its role in choline uptake. Journal of Neurochemistry, 110(4), 1297-1309, 2009 IF = 3,999(09) 4. Bouřová L. - Stöhr J. - Lisý V. - Rudajev V. - Novotný J. - Svoboda P. G-protein activity in Percoll-purified plasma membranes, bulk plasma membranes, and low-density plasma membranes isolated from rat cerebral cortex. Medical Science Monitor, 15(4), BR111-BR122, 2009 IF = 1,543(09) 2008 1. Machová E. - Jakubík J. - Michal P. - Oksman M. - Iivonen H. - Tanila H. - Doležal V. Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice. Neurobiology of Aging, 29(3), 368-378, 2008 IF = 5,959(08) 2. Drastichová Z. - Bouřová L. - Lisý V. - Hejnová L. - Rudajev V. - Stöhr J. - Durchánková D. - Ostašov P. - Teisinger J. - Soukup T. - Novotný J. - Svoboda P. Subcellular redistribution of trimeric G-proteins – potential mechanism of desensitization of hormone response: internalisation, solubilization, down-regulation. Physiological Research, 57, S1-S10, 2008 IF = 1,653(08) 2007 1. Machová E. - Jakubík J. - El-Fakahany E. E. - Doležal V. Wash-Resistantly Bound Xanomeline Inhibits Acetylcholine Release by Persistent Activation of Presynaptic M2 and M4 Muscarinic Receptors in Rat Brain. Journal of Pharmacology and Experimental Therapeutics, 322(1), 316-323, 2007 IF = 4,003(07) 2. Michal P. - El-Fakahany E. E. - Doležal V. Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins. Journal of Pharmacology and Experimental Therapeutics, 320(2), 607-614, 2007 IF = 4,003(07) 2006 1. Jakubík J. - Doležal V. Determinants of positive cooperativity between strychnine-like allosteric modulators and N-methylscopolamine at muscarinic receptors. Journal of Molecular Neuroscience, 30(1-2), 111-112, 2006 IF = 2,965(06) 2. Machová E. - Nováková J. - Lisá V. - Doležal V. Docosahexaenoic acid supports cell growth and expression of choline acetyltransferase and muscarinic receptors in NG108-15 cell line. Journal of Molecular Neuroscience, 30(1-2), 25-26, 2006 IF = 2,965(06) 3. Bruce A. W. - Krejčí A. - Ooi L. - Deuchars J. - Wood I. C. - Doležal V. - Buckley N. J. The transcriptional repressor REST is a critical regulator of the neurosecretory phenotype. Journal of Neurochemistry, 98(6), 1828-1840, 2006 IF = 4,26(06) 4. Jakubík J. - El-Fakahany E. E. - Doležal V. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors. Molecular Pharmacology, 70(2), 656-666, 2006 IF = 4,469(06) 5. Machová E. - Málková B. - Lisá V. - Nováková J. - Doležal V. The increase of choline acetyltransferase activity by docosahexaenoic acid in NG108-15 cells grown in serum-free medium is independent of its effect on cell growth. Neurochemical Research, 31(10), 1239-1246, 2006 IF = 2,139(06) 2005 1. Nováková J. - Mikasová L. - Machová E. - Lisá V. - Doležal V. Chronic treatment with amyloid beta(1-42) inhibits non-cholinergic high-affinity choline transport in NG108-15 cells through protein kinase C signaling. Brain Research, 1062(1-2), 101-110, 2005 IF = 2,296(05) 2. Matoušek P. - Novotný J. - Rudajev V. - Svoboda P. Prolonged agonist stimulation does not alter the protein composition of membrane domains in spite of dramatic changes induced in a specific signaling cascade. Cell Biochemistry and Biophysics, 42(1), 21-40, 2005 IF = 2,138(05) 3. Rudajev V. - Novotný J. - Hejnová L. - Milligan G. - Svoboda P. Dominant portion of thyrotropin-releasing hormone receptor is excluded from lipid domains. Detergent-resistant and detergent-sensitive pools of TRH receptor and Gq alpha/G11 alpha protein. Journal of Biochemistry, 138(2), 111-125, 2005 IF = 1,827(05) 4. Jakubík J. - Krejčí A. - Doležal V. Asparagine, valine, and threonine in the third extracellular loop of muscarinic receptor have essential roles in the positive cooperativity of strychnine-like allosteric modulators. Journal of Pharmacology and Experimental Therapeutics, 313(2), 688-696, 2005 IF = 4,098(05) 2004 1. Mysliveček J. - Říčný J. - Palkovits M. - Kvetňanský R. The effects of short-term immobilization stress on muscarinic receptors, beta-adrenoceptors, and adenylyl cyclase in different heart regions. Annals of the New York Academy of Sciences, 1018(), 315-322, 2004 IF = 1,789(04) 2. Moravcová Z. - Rudajev V. - Stöhr J. - Novotný J. - Černý J. - Parenti M. - Milligan G. - Svoboda P. Long-term agonist stimulation of IP prostanoid receptor depletes the cognate G(s)alpha protein in membrane domains but does not change the receptor level. Biochimica et Biophysica Acta-Molecular Cell Research, 1691(1), 51-65, 2004 IF = 3,482(04) 3. Krejčí A. - Bruce A.W. - Doležal V. - Tuček S. - Buckley N.J. Multiple promoters drive tissue-specific expression of the human M muscarinic acetylcholine receptor gene. Journal of Neurochemistry, 91(1), 88-98, 2004 IF = 4,824(04) 4. Jakubík J. - Tuček S. - El-Fakahany E.E. Role of receptor protein and membrane lipids in xanomeline wash-resistant binding to muscarinic M1 receptors. Journal of Pharmacology and Experimental Therapeutics, 308(1), 105-110, 2004 IF = 4,335(04) 5. Lazareno S. - Doležal V. - Popham A. - Birdsall N.J.M. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. Molecular Pharmacology, 65(1), 257-266, 2004 IF = 5,08(04) 6. Krejčí A. - Michal P. - Jakubík J. - Říčný J. - Doležal V. Regulation of signal transduction at M2 muscarinic receptor. Physiological Research, 53(Suppl.1), S131-S140, 2004 IF = 1,14(04) 7. Svoboda P. - Teisinger J. - Novotný J. - Bouřová L. - Drmota T. - Hejnová L. - Moravcová Z. - Lisý V. - Rudajev V. - Stöhr J. - Vokurková A. - Švandová I. - Durchánková D. Biochemistry of transmembrane signaling mediated by trimeric G proteins. Physiological Research, 53(Suppl. 1), S141-S152, 2004 IF = 1,14(04) 2003 1. Mysliveček J. - Říčný J. - Kolář F. - Tuček S. The effects of hydrocortisone on rat heart muscarinic and adrenergic alpha(1), beta(1) and beta(2) receptors, propranolol-resistant binding sites and on some subsequent steps in intracellular signalling. Naunyn-Schmiedebergs Archives of Pharmacology, 368(5), 366-376, 2003 IF = 2,101(03) 2. Doležal V. - Kašparová J. Beta-amyloid and cholinergic neurons. Neurochemical Research, 28(3-4), 499-506, 2003 IF = 1,511(03) 2002 1. Jakubík J. - Tuček S. - El-Fakahany E.E. Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor. Journal of Pharmacology and Experimental Therapeutics, 301(3), 1033-1041, 2002 IF = 3,991(02) 2. Castell X. - Diebler M.F. - Tomasi M. - Bigari C. - De Gois S. - Berrard S. - Mallet J. - Israël M. - Doležal V. More than one way to toy with ChAT and VAChT. Journal of Physiology-Paris, 96(1-2), 61-72, 2002 IF = 1,07(02) 3. Krejčí A. - Tuček S. Quantitation of mRNAs for M(1) to M(5) subtypes of muscarinic receptors in rat heart and brain cortex. Molecular Pharmacology, 61(6), 1267-1272, 2002 IF = 5,48(02) 4. Říčný J. - Gualtieri F. - Tuček S. Constitutive inhibitory action of muscarinic receptors on adenylyl cyclase in cardiac membranes and its stereospecific suppression by hyoscyamine. Physiological Research, 51(2), 131-137, 2002 IF = 0,984(02) 5. Tuček S. - Michal P. - Vlachová V. Modelling the consequences of receptor-G-protein promiscuity. Trends in Pharmacological Sciences, 23(4), 171-176, 2002 IF = 13,276(02) 2001 1. Doležal V. - Lisá V. - Diebler M.F. - Kašparová J. - Tuček S. Differentiation of NG108-15 cells induced by the combined presence of dbcAMP and dexamethasone brings about the expression of N and P/Q types of calcium channels and the inhibitory influence of muscarinic receptors on calcium influx. Brain Research, 910(1-2), 134-141, 2001 IF = 2,489(01) 2. Doležal V. - Castell X. - Tomasi M. - Diebler M.F. Stimuli that induce a cholinergic neuronal phenotype of NG108-15 cells upregulate ChAT and VAChT mRNAs but fail to increase VAChT protein. Brain Research Bulletin, 54(4), 363-373, 2001 IF = 1,783(01) 3. Michal P. - Lysíková M. - Tuček S. Dual effects of muscarinic M2 acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists. British Journal of Pharmacology, 132(6), 1217-1228, 2001 IF = 3,502(01) 4. Tuček S. - Michal P. - Vlachová V. Dual effects of muscarinic M2 receptors on the synthesis of cyclic AMP in CHO cells: background and model. Life Sciences, 68(22-23), 2501-2510, 2001 IF = 1,758(01) 5. Krejčí A. - Tuček S. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors. Molecular Pharmacology, 60(4), 761-767, 2001 IF = 5,297(01) 6. Kašparová J. - Lisá V. - Tuček S. - Doležal V. Chronic exposure of NG108-15 cells to amyloid beta peptide (A beta(1-42)) abolishes calcium influx via N-type calcium channels. Neurochemical Research, 26(8-9), 1079-1084, 2001 IF = 1,638(01) 7. Lysíková M. - Havlas Z. - Tuček S. Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and Carboxyl C atoms in the molecules of antagonists. Neurochemical Research, 26(4), 383-394, 2001 IF = 1,638(01) 2000 1. Jakubík J. - El-Fakahany E.E. - Tuček S. Evidence for a tandem two-site model of ligand binding to muscarinic acetylcholine receptors. Journal of Biological Chemistry, 275(25), 18836-18844, 2000 IF = 7,368(00) 1999 1. Doležal V. - Tuček S. Calcium channels involved in the inhibition of acetylcholine release by presynaptic muscarinic receptors in rat striatum. British Journal of Pharmacology, 127, 1627-1632, 1999 IF = 3,722(99) 2. Lysíková M. - Fuksová K. - Elbert T. - Jakubík J. - Tuček S. Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters. British Journal of Pharmacology, 127, 1240-1246, 1999 IF = 3,722(99) 3. Michal P. - Lysíková M. - El-Fakahany E.E. - Tuček S. Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors. European Journal of Pharmacology, 376, 119-125, 1999 IF = 2,047(99) 1998 1. Doležal V. - Tuček S. The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists. British Journal of Pharmacology, 124, 1213-1218, 1998 IF = 3,704(98) 2. Diebler M.F. - Tomasi M. - Meunier F.M. - Israel M. - Doležal V. Influence of retinoic acid and of cyclic AMP on the expression of choline acetyltransferase and of vesicular acetylcholine transporter in NG108-15 cells. Journal of Physiology-Paris, 92, 379-384, 1998 IF = 0,639(98) 3. Tuček S. - Jakubík J. - Doležal V. - El-Fakahany E.E. Positive effects of allosteric modulators on the binding properties and the function of muscarinic acetylcholine receptors. Journal of Physiology-Paris, 92, 241-243, 1998 IF = 0,639(98) 4. Mysliveček J. - Lisá V. - Trojan S. - Tuček S. Heterologous regulation of muscarinic and beta-adrenergic receptors in rat cardiomyocytes in culture. Life Sciences, 63(13), 1169-1182, 1998 IF = 1,937(98) 5. Jakubík J. - Haga T. - Tuček S. Effects of an agonist, allosteric modulator, and antagonist on guanosine-gamma-[35S]thiotriphosphate binding to liposomes with varying muscarinic receptor/Go protein stoichiometry. Molecular Pharmacology, 54(5), 899-906, 1998 IF = 5,428(98) 1997 1. Doležal V. - Lisá V. - Tuček S. Effect of tacrine on intracellular calcium in cholinergic SN56 neuronal cells. Brain Research, 769(2), 219-224, 1997 IF = 2,119(97) 2. Doležal V. - Lisá V. - Tuček S. Differential effects of the M1-M5 muscarinic acetylcholine receptor subtypes on intracellular calcium and on the incorporation of choline into membrane lipids in genetically modified Chinese hamster ovary cell lines. Brain Research Bulletin, 42(1), 71-78, 1997 IF = 1,708(97) 3. Jakubík J. - Bačáková L. - El-Fakahany E.E. - Tuček S. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Molecular Pharmacology, 52, 172-179, 1997 IF = 4,921(97) 4. Tuček S. Is the R and R* dichotomy real. Trends in Pharmacological Sciences, 18, 414-416, 1997 IF = 12,323(97) 1996 1. Doležal V. - Lee K. - Schobert A. - Hertting G. The influx Ca 2+ and the release of noradrenaline evoked by the stimulation of presynaptic nicotinic receptors of chick sympathetic neurons in culture are not mediated via L-, N-, or P-type calcium channels. Brain Research, 740(1), 75-80, 1996 IF = 2,526(96) 2. Doležal V. - Huang H. - Schobert A. - Hertting G. 3,4-Diaminopyridine masks the inhibition of noradrenaline from chick sympathetic neurons via presynaptic alpha2-adrenoceptors:insights into the role of N-and L-type calcium channels. Brain Research, 721(1,2), 101-110, 1996 IF = 2,526(96) 3. Proška J. - Tuček S. Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors. European Journal of Pharmacology, 305, 201-205, 1996 IF = 2,339(96) 4. Mysliveček J. - Trojan S. - Tuček S. Biphasic changes in the density of muscarinic and beta-adrenergic receptors in cardiac atria of rats treated with diisopropylfluorophosphate. Life Sciences, 58(26), 2423-2430, 1996 IF = 2,352(96) 5. Jakubík J. - Bačáková L. - Lisá V. - El-Fakahany E.E. - Tuček S. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proceedings of the National Academy of Sciences of the United States of America, 93(16), 8705-8709, 1996 IF = 10,244(96) 1995 1. Hejnová L. - Tuček S. - El-Fakahany E.E. Positive and negative allosteric interactions on muscarinic receptors. European Journal of Pharmacology, 291, 427-430, 1995 IF = 2,637(95) 2. Jakubík J. - Tuček S. Positive allosteric interactions on cardiac muscarinic receptors:effects of chemical modifications of disulphide and carboxyl groups. European Journal of Pharmacology, 289(1), 311-319, 1995 IF = 2,637(95) 3. Jakubík J. - Bačáková L. - El-Fakahany E.E. - Tuček S. Constitutive activity of the M1 - M4 subtypes of muscarinic receptors in transfeced CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists. FEBS Letters, 337, 275-279, 1995 IF = 3,842(95) 4. Doležal V. - Schobert A. - Hertting G. Presynaptic nicotinic receptors stimulate increases in intraterminal calcium of chick sympathetic neurons in culture. Journal of Neurochemistry, 65(4), 1874-1879, 1995 IF = 4,852(95) 5. Jakubík J. - Bačáková L. - El-Fakahany E.E. - Tuček S. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. Journal of Pharmacology and Experimental Therapeutics, 274(3), 1077-1083, 1995 IF = 3,582(95) 6. Proška J. - Tuček S. Competition between positive and negative allosteric effectors on muscarinic receptors. Molecular Pharmacology, 48, 696-702, 1995 IF = 6,58(95) 7. Doležal V. - Schobert A. - Hertting G. Differences of the electrical and nicotinic receptor stimulation-evoked liberation of norepinephrine from chicken sympathetic neurons in culture:possible involvement of different pools of the transmitter. Neurochemical Research, 20(3), 261-267, 1995 IF = 1,577(95) 8. Musílková J. - Tuček S. Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors. Neurochemistry International, 27(4/5), 337-343, 1995 IF = 2,236(95) 9. Tuček S. - Proška J. Allosteric modulation of muscarinic acetylcholine receptors. Trends in Pharmacological Sciences, 16(1), 205-212, 1995 IF = 17,556(95) 1994 1. Jakubík J. - Tuček S. Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation. British Journal of Pharmacology, 113, 1529-1537, 1994 IF = 4,695(94) 2. Jakubík J. - Tuček S. Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium. Journal of Neurochemistry, 63(5), 1932-1940, 1994 IF = 4,525(94) 3. Proška J. - Tuček S. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Molecular Pharmacology, 45(4), 709-717, 1994 IF = 5,927(94) 4. Doležal V. - Schobert A. - Hertting G. Presynaptic alpha2-adrenoreceptors inhibit calcium influx in terminals of chicken sympathetic neurons and noradrenaline release evoked by nicotinic stimulation. Neuroscience Letters, 180(1), 63-66, 1994 IF = 2,703(94) 1993 1. Doležal V. - Sbia M. - Diebler M. F. - Varoqui H. - Morel N. Effect of N,N'-dicyclohexylcarbodiimide on compartmentation and release of newly synthetized and preformed acetylcholine in Torpedo synaptosomes. Journal of Neurochemistry, 61(4), 1454-1460, 1993 IF = 4,223(93) 2. Doležal V. - Tuček S. Presynaptic muscarinic receptors and the release of acetylcholine from cerebrocortical prisms: roles of Ca+2++ and K++ concentration. Naunyn-Schmiedebergs Archives of Pharmacology, 348, 228-233, 1993 IF = 3(93) 3. Mareš P. - Seidl J. - Nováková J. Differential action of phenytoin and carbamazepine on cortical interhemispheric responses in young but not in adult rats. Neuroscience Letters, 160(1), 49-52, 1993 IF = 2,645(93) 4. Mysliveček J. - Tuček S. Binding of phenylcyclohexylglycoloyl ester of hydroxyethyldimethylhydrazonium (compound VUFB-3113) to muscarinic receptors in rat heart, salivary gland and cerebral cortex. Physiological Research, 42(6), 433-435, 1993 IF = 0,3(93) 5. Tuček S. Short-term Control of the Synthesis of Acetylcholine. Progress in Biophysics and Molecular Biology, 60, 59-69, 1993 IF = 5,148(93) |